February 12, 2025 / 12:33 IST
Reported Standalone quarterly numbers for Akums Drugs & Pharmaceuticals are:Net Sales at Rs 337.41 crore in December 2024 down 11.94% from Rs. 383.15 crore in December 2023.
Story continues below Advertisement
Quarterly Net Profit at Rs. 41.17 crore in December 2024 up 40.3% from Rs. 29.34 crore in December 2023.
EBITDA stands at Rs. 67.87 crore in December 2024 up 19.89% from Rs. 56.61 crore in December 2023.
Akums Drugs & P EPS has increased to Rs. 2.69 in December 2024 from Rs. 2.05 in December 2023.
Akums Drugs & P shares closed at 541.95 on February 10, 2025 (NSE)
| Akums Drugs & Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 337.41 | 328.35 | 383.15 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 337.41 | 328.35 | 383.15 | | EXPENDITURE | | Consumption of Raw Materials | 206.62 | 196.47 | 242.09 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 7.85 | -6.07 | 0.02 | | Power & Fuel | -- | -- | -- | | Employees Cost | 50.34 | 50.38 | 46.26 | | Depreciation | 10.68 | 9.39 | 8.31 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 38.56 | 44.51 | 63.06 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 23.34 | 33.68 | 23.41 | | Other Income | 33.84 | 32.12 | 24.89 | | P/L Before Int., Excpt. Items & Tax | 57.19 | 65.80 | 48.30 | | Interest | 2.29 | 4.18 | 4.84 | | P/L Before Exceptional Items & Tax | 54.89 | 61.62 | 43.46 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 54.89 | 61.62 | 43.46 | | Tax | 13.72 | 11.25 | 14.11 | | P/L After Tax from Ordinary Activities | 41.17 | 50.37 | 29.34 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 41.17 | 50.37 | 29.34 | | Equity Share Capital | 30.62 | 30.62 | 28.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 2.69 | 3.38 | 2.05 | | Diluted EPS | 2.69 | 3.38 | -- | | EPS After Extra Ordinary | | Basic EPS | 2.69 | 3.38 | 2.05 | | Diluted EPS | 2.69 | 3.38 | -- | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
